APA

Horáková D., Kýr M., Havrdová E., Doležal O., Lelková P., Pospíšilová L., Bergsland N., Dwyer M. G., Cox J. L., Hussein S., Seidl Z., Vaněčková M., Krásenský J. & Zivadinov R. (20110627). Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study. : Folia biologica.

Chicago

Horáková D, Kýr M, Havrdová E, Doležal O, Lelková P, Pospíšilová L, Bergsland N, Dwyer M G, Cox J L, Hussein S, Seidl Z, Vaněčková M, Krásenský J and Zivadinov R. 20110627. Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study. : Folia biologica.

Harvard

Horáková D., Kýr M., Havrdová E., Doležal O., Lelková P., Pospíšilová L., Bergsland N., Dwyer M. G., Cox J. L., Hussein S., Seidl Z., Vaněčková M., Krásenský J. and Zivadinov R. (20110627). Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study. : Folia biologica.

MLA

Horáková D, Kýr M, Havrdová E, Doležal O, Lelková P, Pospíšilová L, Bergsland N, Dwyer M G, Cox J L, Hussein S, Seidl Z, Vaněčková M, Krásenský J and Zivadinov R. Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study. : Folia biologica. 20110627.